Front. Cardiovasc. Med. Frontiers in Cardiovascular Medicine Front. Cardiovasc. Med. 2297-055X Frontiers Media S.A. 10.3389/fcvm.2025.1656799 Cardiovascular Medicine Correction Correction: Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study LaurentEmeline 1 2 GodillonLucile 1 * † TassiMarc-Florent 1 3 MarcolletPierre 4 ChassaingStéphan 5 DecomisMarie 6 BezinJulien 7 LaureChristophe 8 AngoulvantDenis 9 10 RangeGrégoire 8 Grammatico-GuillonLeslie 1 10 Public Health Unit, Epidemiology, Teaching Hospital of Tours, Tours, France Research Unit EA 7505 “Education, Ethics and Health”, University of Tours, Tours, France Faculty of Pharmacy, University of Tours, Tours, France Cardiology Department, CH Bourges, Bourges, France Cardiology Department, Private Hospital NCT+, Tours, France Cardiology Department, Private Hospital Oréliance, Orléans, France Clinical Pharmacology Unit, University of Bordeaux, INSERM, BPH, Team AHeaD, Bordeaux, France Cardiology Department, Les Hôpitaux de Chartres, Chartres, France Cardiology Department, Teaching Hospital of Tours, Tours, France Faculty of Medicine, University of Tours, Tours, France

Edited and Reviewed by: Tommaso Gori, Johannes Gutenberg University Mainz, Germany

 Correspondence: Lucile Godillon l.godillon@chu-tours.fr; leslie.guillon@univ-tours.fr

ORCID Lucile Godillon orcid.org/0000-0002-3852-2846

 11092025 2025 121656799 30062025 27082025 © 2025 Laurent, Godillon, Tassi, Marcollet, Chassaing, Decomis, Bezin, Laure, Angoulvant, Range and Grammatico-Guillon. 2025Laurent, Godillon, Tassi, Marcollet, Chassaing, Decomis, Bezin, Laure, Angoulvant, Range and Grammatico-Guillon

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Correction on Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ study By Laurent E, Godillon L, Tassi M-F, Marcollet P, Chassaing S, Decomis M, Bezin J, Laure C, Angoulvant D, Range G and Grammatico-Guillon L (2025). Front. Cardiovasc. Med. 12:1484401. doi: 10.3389/fcvm.2025.1484401 myocardial infarction (MI) cardiac rehabilitation compliance outcome probabilistic matching section-at-acceptanceCoronary Artery Disease

The figures were in the wrong order in the PDF and HTML version of this paper. Figure 2 should have been figure 3 and vice versa. The order has now been corrected.

Factors associated with an ischemic complication and/or death at 1 year after STEMI—the STOP—SCA+ study. LVEF, left ventricular ejection fraction.

Forest plot showing adjusted hazard ratios with 95 percent confidence intervals for various factors, including age over sixty-five, gender, renal impairment, diabetes, Killip class, low LVEF, no cardiac rehabilitation, and non-compliance to cardiac therapy. Renal impairment has the highest hazard ratio at approximately 2.87.

Factors associated with compliance for the cardiac tri-therapy (PDC ≥80%) at 1 year after STEMI-the STOP-SCA+ study. TCA, transluminal coronary angioplasty; GP, general practitioner.

Forest plot showing adjusted odds ratios with 95 percent confidence intervals for various factors: age under 65 years, men, no history of myocardial infarction or coronary bypass, no stroke history, cardiac rehabilitation, and general practitioner follow-up every three months. Each factor's odds ratio exceeds 1, indicating increased likelihood associated with each condition.

The original version of this article has been updated.

Generative AI statement

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

 Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.